References
Pilotto A. Helicobacter pylori-on-associated peptic ulcer disease in older patients: current management strategies. Drugs Aging 2001; 18(7): 487–94
Sung JJY, Gisbert JP, Pajares JM. H. pylori and nonsteroidal antiinflammatory drugs. Curr Opin Gastroenterol 2000; 16 Suppl. 1: S39–43
European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report. Gut 1997; 41: 8–13
NIH Consensus Development Panel on Helicobacter pylori in pepticulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65–9
Pilotto A, Franceschi M, Di Mario F, et al. The long-term clinical outcome of elderly patients with Helicobacter pylori-associated peptic ulcer disease. Gerontology 1998; 44: 153–8
Roll J, Weng A, Newman J. Diagnosis and treatment of Helicobacter pylori infection among California Medicare patients. Arch Intern Med 1997; 157: 994–8
Pilotto A, Franceschi M, Costa MC, et al. Helicobacter pylori test-and-eradication strategy. Lancet 2000; 356: 1683–4
Ofman JJ, Etchason J, Alexander W, et al. The quality of care for Medicare patients with peptic ulcer disease. Am J Gastroenterol 2000; 95: 106–13
Pilotto A, Dal Bo N, Franceschi M, et al. Comparison of three proton pump inhibitors (PPI) in combination with amoxycillin and metronidazole for one week to cure Helicobacter pylori infection in the elderly [abstract]. Gut 1998 Sep; 43 Suppl. 2: 91
Matheson AJ, Jarvis B. Lansoprazole: an update of its place in the management of acid-related disorders. Drugs 2001; 61(12): 1801–33
Pilotto A, DiMario F, Franceschi M, et al. Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. Aliment Pharmacol Ther 1996; 10: 1021–7
Klotz U. Pharmacokinetic considerations in the eradication of Helicobacter pylori. Clin Pharmacokinet 2000; 38: 243–70
Hasselgren G. Pharmacokinetic study of esomeprazole in the elderly. Clin Pharmacokinet 2001; 40: 145–50
Carswell CI, Goa KL. Rabeprazole: an update of its use in acid-related disorders. Drugs 2001; 61(15): 2327–56
Kearney DJ, Brousal A. Treatment of Helicobacter pylori in clinical practice in the United States: results from 224 patients. Dig Dis Sci 2000; 45: 265–71
Lee M, Kemp JA, Canning A, et al. A randomised controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med 1999; 159: 2312–9
De Boer WA, van Etten RJ, Schneeberger PM, et al. A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule. Am J Gastroenterol 2000; 95: 641–5
Pilotto A, Di Mario F, Malfertheiner P, et al. Upper gastrointestinal diseases in the elderly: report of a meeting held at Vicenza, Italy on 20 March 1988. Eur J Gastroenterol Hepatol 1999; 11: 801–8
Dorè MP, Leandro G, Realdi G, et al. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 2000; 45: 68–76
Alsahli M, Farrell RJ, Michetti P. Vaccines: an ongoing promise? Dig Dis 2001; 19(2): 148–57
Rights and permissions
About this article
Cite this article
Treatment of Helicobacter pylori should not be overlooked in the elderly. Drugs Ther. Perspect 18, 12–15 (2002). https://doi.org/10.2165/00042310-200218030-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200218030-00005